The Advantage of Using Immunoinformatic Tools on Vaccine Design and Development for Coronavirus

After the outbreak of SARS-CoV-2 by the end of 2019, the vaccine development strategies became a worldwide priority. Furthermore, the appearances of novel SARS-CoV-2 variants challenge researchers to develop new pharmacological or preventive strategies. However, vaccines still represent an efficient...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Machorro, Jazmín, Ramírez-Salinas, Gema Lizbeth, Martinez-Archundia, Marlet, Correa-Basurto, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693616/
https://www.ncbi.nlm.nih.gov/pubmed/36366353
http://dx.doi.org/10.3390/vaccines10111844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693616/
https://www.ncbi.nlm.nih.gov/pubmed/36366353
http://dx.doi.org/10.3390/vaccines10111844

Ejemplares similares